SBIR/STTR Research Award
PULSED LASER TREATMENT OF PIGMENTED LESIONS
Award amount
$500,000Program and phase
SBIR · Phase IIAward year
1990Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- CANDELA CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
CUTANEOUS PIGMENTED LESIONS ARE EXTREMELY COMMON IN DERMATOLOGY. ALTHOUGH THE MAJORITY OF THESE LESIONS ARE BENIGN, THE POSSIBILITY OF MALIGNANT TRANSFORMATION IN ADDITION TO COSMETIC CONSIDERATIONS HAVE FREQUENTLY NECESSITATED THEIR THERAPEUTIC REMOVAL. THE LASER COULD BE APPROPRIATELY ADAPTED TO SELECTIVELY DESTROY ONLY PIGMENT CELLS WHILE MINIMIZING INJURY TO THE SURROUNDING STRUCTURE, THUS PROVIDING A LESS TRAUMATIC ALTERNATIVE WITH REDUCED SCARRING TO SURGICAL EXCISION OR DERMABRASION. CANDELA LASER CORPORATION AND BOSTON UNIVERSITY SCHOOL OF MEDICINE WILL CONDUCT IN VIVO STUDIES EMPLOYING PIGSKIN TO DETERMINE THE OPTIMUM LASER-OPERATING PARAMETERS OF WAVELENGTH, ENERGY DENSITY, AND PULSE DURATION FOR EFFECTIVETREATMENT OF PIGMENTED LESIONS. IT IS PLANNED TO DEVELOP A FLASHLAMP-EXCITED DYE LASER AND A SOLID-STATE LASER FOR THISSTUDY AND TO COMPARE THE MERITS OF EACH IN THE TREATMENT OF PIGMENTED LESIONS. IF SUCCESSFUL, CLINICAL TRIALS AND PROTOTYPE PRODUCT DEVELOPMENT WILL BE UNDERTAKEN IN PHASE II.
Technology keywords
Not reported